Finland · Delayed Price · Currency is EUR Aiforia Technologies Oyj Company Description
Aiforia Technologies Oyj, together with its subsidiary Aiforia Inc., equips pathologists and scientists in preclinical, clinical, and academic labs with deep learning artificial intelligence (AI) software in Finland, the rest of Europe, North America, and internationally.
It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application.
The company’s products are used for the treatment of Parkinson’s disease, organ transplantation, and liver and inflammatory bowel diseases.
It serves academic institutes and pharmaceutical companies through direct and partner sales. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.
| Country | Finland |
| Founded | 2013 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 77 |
| CEO | Jukka Tapaninen |
Contact Details
Address: Pursimiehenkatu 29-31 D 610 Helsinki, 00150 Finland | |
| Phone | 358 2073 49130 |
| Website | aiforia.com |
Stock Details
| Ticker Symbol | AIFORIA |
| Exchange | Nasdaq Helsinki |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Jukka Tapaninen M.Sc(Econ) | Chief Executive Officer |
| Dr. Johan Lundin M.D., Ph.D. | Co- Founder and Director |
| Veli-Matti Parkkonen | Chief Financial Officer |
| Kaisa Helminen | Chief Operating Officer |
| Panu Kauppila | Chief Technology Officer and Chief Product Officer |
| Manuel Ahlsten | Vice President of Marketing |
| Tamas Regenyi | Chief Commercial Officer |